Prolongation of metallothionein induction combats Aß and α-synuclein toxicity in aged transgenic Caenorhabditis elegans.

Scientific Reports
Dagmar PretschAlexander Pretsch

Abstract

Neurodegenerative disorders (ND) like Alzheimer's (AD), Parkinson's (PD), Huntington's or Prion diseases share similar pathological features. They are all age dependent and are often associated with disruptions in analogous metabolic processes such as protein aggregation and oxidative stress, both of which involve metal ions like copper, manganese and iron. Bush and Tanzi proposed 2008 in the 'metal hypothesis of Alzheimer's disease' that a breakdown in metal homeostasis is the main cause of NDs, and drugs restoring metal homeostasis are promising novel therapeutic strategies. We report here that metallothionein (MT), an endogenous metal detoxifying protein, is increased in young amyloid ß (Aß) expressing Caenorhabditis elegans, whereas it is not in wild type strains. Further MT induction collapsed in 8 days old transgenic worms, indicating the age dependency of disease outbreak, and sharing intriguing parallels to diminished MT levels in human brains of AD. A medium throughput screening assay method was established to search for compounds increasing the MT level. Compounds known to induce MT release like progesterone, ZnSO4, quercetin, dexamethasone and apomorphine were active in models of AD and PD. Thioflavin T, clioquinol a...Continue Reading

References

Jun 1, 1988·Molecular Endocrinology·E P SlaterM Beato
May 1, 1974·Genetics·S Brenner
Jun 29, 2000·Biochemical and Biophysical Research Communications·M OhtaS Kuno
Mar 14, 2001·Brain Research·W H YuP E Fraser
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D BarsyteG J Lithgow
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
May 23, 2002·Cellular and Molecular Life Sciences : CMLS·P CoyleA M Rofe
Feb 26, 2003·Neurobiology of Aging·Christopher D LinkBarbara G Sahagan
Aug 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Trent NguyenStephen M Massa
Dec 15, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yanjue WuYuan Luo
Apr 21, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hui-Ju LinFuu-Jen Tsai
Nov 21, 2007·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Andreas KampkötterWim Wätjen
Dec 1, 2007·WormBook : the Online Review of C. Elegans Biology·Theresa Stiernagle
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ashley I Bush, Rudolph E Tanzi
Jul 21, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·George C-T JiangMichael Aschner
Jun 3, 2010·Cold Spring Harbor Protocols·Donald C RioTimothy W Nilsen
Oct 12, 2010·Ageing Research Reviews·William R Swindell
Mar 10, 2011·Annals of Neurology·Eri HimenoJun-ichi Kira
Mar 30, 2011·Journal of Visualized Experiments : JoVE·Gregory M Solis, Michael Petrascheck
Jun 3, 2011·Journal of Visualized Experiments : JoVE·Chi K LeungKeith P Choe
Nov 13, 2012·Free Radical Biology & Medicine·Scott AytonAshley I Bush
Jan 11, 2013·Cell Death & Disease·T C JacksonP M Kochanek
Apr 3, 2013·Biological & Pharmaceutical Bulletin·Hirokazu HaraTetsuo Adachi
Aug 8, 2014·Chemical Society Reviews·Kevin J Barnham, Ashley I Bush
Jan 3, 2015·Aging·Ida M KlangGordon J Lithgow
Apr 24, 2015·Genetics·Rafael L Gomez-AmaroMichael Petrascheck

❮ Previous
Next ❯

Citations

Nov 26, 2020·Metallomics : Integrated Biometal Science·Jemmyson Romário de Jesus, Marco Aurélio Zezzi Arruda
Dec 10, 2020·Metallomics : Integrated Biometal Science·Ashima BhattacharjeeKaustav Chakraborty
Jul 25, 2021·International Journal of Molecular Sciences·Namdoo Kim, Hyuck Jin Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
Fluorescence
PCR

Software Mentioned

Graphpad Prism
Excel
MS

Related Concepts

Related Feeds

Alzheimer's Disease: RNA Regulation

RNA regulation involves several mechanisms that are used by cells to decrease or increase the production of RNA. Disruption of RNA regulatory processes has been associated with Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA regulation and AD.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.